Tibet Weixinkang Medicine Co., Ltd. logo

Tibet Weixinkang Medicine Co., Ltd. (603676)

Market Closed
11 Aug, 06:57
SSE SSE
¥
9. 18
-0.29
-3.0623%
¥
4.06B Market Cap
- P/E Ratio
0.65% Div Yield
4.96M Volume
- Eps
¥ 9.47
Previous Close
Add Transaction
Day Range
9.17 9.4
Year Range
7.82 13.61
Want to track 603676 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603676 closed today lower at ¥9.18, a decrease of -3.0623% from yesterday's close, completing a monthly increase of 13.7546% or ¥1.11. Over the past 12 months, 603676 stock lost -13.1504%.
603676 pays dividends to its shareholders, with the most recent payment made on Jun 29, 2026. The next estimated payment will be in In 4 months on Dec 29, 2026 for a total of ¥0.18.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

603676 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Tibet Weixinkang Medicine Co., Ltd. (603676) FAQ

What is the stock price today?

The current price is ¥9.18.

On which exchange is it traded?

Tibet Weixinkang Medicine Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603676.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.65%.

What is its market cap?

As of today, the market cap is 4.06B.

Has Tibet Weixinkang Medicine Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Tibet Weixinkang Medicine Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yong Zhang CEO
SSE Exchange
CNE100002QQ3 ISIN
CN Country
701 Employees
29 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Tibet Weixinkang Medicine Co., Ltd. is a leading enterprise in the pharmaceutical sector, focusing on the research, development, production, and sale of chemical drugs and their bulk drugs within China. Founded in 2006 and based in Lhasa, the company has carved a niche for itself by producing a wide range of medical products aimed at improving patient care and treatment. Initially known as Weixinkang Medicine Youxian Gongsi, it underwent a name change in 2015 to better reflect its expanding capabilities and commitment to excellence in the medicinal field. With its continued focus on innovation and quality, Tibet Weixinkang Medicine Co., Ltd. has established a strong presence in the pharmaceutical industry.

Products and Services

Tibet Weixinkang Medicine Co., Ltd. offers a diverse portfolio of pharmaceutical products and services, tailored to meet the evolving needs of healthcare providers and patients. Here's a closer look at some of their key offerings:

  • Parenteral Nutrition Vitamins: These are specialized formulations designed to provide essential vitamins directly into the bloodstream for patients who are unable to consume food orally. They play a crucial role in medical treatments requiring intensified nutritional support.
  • Electrolyte Supplements: Essential for maintaining hydration and electrolyte balance, these supplements are used in various medical conditions to prevent dehydration and electrolyte imbalances in patients.
  • Intravenous Iron Supplements: Aimed at treating iron deficiency and anemia, these supplements are administered intravenously to ensure rapid and effective absorption by the body.
  • Antibiotics: The company produces a range of antibiotics used to fight bacterial infections, demonstrating its commitment to combating infectious diseases.
  • Medicine for digestive system and liver diseases: These medications are designed to treat a wide array of digestive and liver conditions, improving patients' overall health and well-being.
  • Injection Multivitamins: Injectable multivitamins offer a quick and effective method to deliver essential vitamins directly into the bloodstream, ensuring prompt nutritional support.
  • Potassium Magnesium Aspartate for Injection: This product is used to treat and prevent low blood levels of potassium and magnesium, critical for heart and muscle function.
  • Iron Sucrose Injection: A safe and effective treatment for iron deficiency anemia, this injection provides a critical component necessary for the formation of red blood cells.
  • Potassium Aspartate Injection: Specifically tailored to address potassium deficiencies, this injection plays a key role in maintaining the body's electrolyte balance.

Contact Information

Address: Building 4, Lhasa, China, 850000
Phone: 86 89 1660 1760